Loading provider…
Loading provider…
Gastroenterology Physician in Houston, TX
NPI: 1306287370Primary Practice Location
Vikram S. Jayanty,M.D.,PA
10837 Katy Fwy, Houston, TX
Primary Employer
Vikram S. Jayanty,M.D.,PA
houstongidocs.com
HQ Phone
Get M.D. Julien's Phone NumberMobile
Get M.D. Julien's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
WI State Medical License
TX State Medical License
TX State Medical License
2023 - 2026
WY State Medical License
2019 - 2025
WI State Medical License
2016 - 2019
MA State Medical License
2013 - 2016

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Gastroenterology
Aurora Health Care
Fellowship • Gastroenterology
2016 - 2019
UMass Chan Medical School
umassmed.edu
Residency • Internal Medicine
2013 - 2016
St Joseph's University Medical School
Medical School
Until 2012
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 215 | 270 |
| 2 | 43239Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | 163 | 173 |
| 3 | 45380Biopsy of the large bowel using an endoscope (colonoscopy) | 149 | 149 |
| 4 | 45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 87 | 87 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 87 | 87 |
Smoking Cessation in a Chronic Pancreatitis Population.
Authors: Samuel Han, Joan Kheder
Publication Date: 2016-04-22
Clostridium difficile in inflammatory bowel disease: a retrospective study
Authors: Gillespie, William, Marya, Neil, Fahed, Julien, Leslie, Gregory, Patel, Krunal, Cave, David R
Journal: Gastroenterol Res Pract
Publication Date: 2017-10-04
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Mirikizumab, DRUG: Ustekinumab